Osimertinib (osi) after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable stage (stg) III epidermal growth factor receptor-mutated (EGFRm) NSCLC: Primary results of the phase 3 LAURA study

Ramalingam S. S., Kato T., Dong X., Ahn M., Quang L., Soparattanapaisarn N., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, sa.17_SUPPL, 2024 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Özet
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1200/jco.2024.42.17_suppl.lba4
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet